Rapamycin Enhanced the Antitumor Effects of Doxorubicin in Myelogenous Leukemia K562 Cells by Downregulating the mTOR/p70S6K Pathway
Oncology Letters - Greece
doi 10.3892/ol.2019.10589
Full Text
Open PDFAbstract
Available in full text
Date
July 9, 2019
Authors
Publisher
Spandidos Publications